:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Prostate Cancer News
Prostate Cancer Breakthrough News

December 06, 2013
Prostate Cancer Study Finds With Drug Combo  
Ron Winslow, Wall Street Journal 

Men with advanced prostate cancer survived significantly longer on a combination of two types of drugs than if they were started on the standard single treatment, according to a major federally sponsored study, which researchers suggested should change the way many such patients are treated.


< READ MORE >

 






April 09, 2013
Selenium-Prostate Cancer Link Again Under Debate 
Charlene Laino, Senior Writer, Gupta Guide

A large Dutch prospective cohort study showing that high selenium levels are associated with a significantly reduced risk of advanced prostate cancer has resurrected a debate many thought was buried.

In the study of over 2,000 men, those with the highest levels of toenail selenium were 63% less likely to develop Stage III/IV prostate cancer than men with the lowest toenail selenium levels (P<0.001).
< READ MORE >


February 14, 2013
Clues Found to Prostate Cancer Upgrading in Watchful Waiting 
Charles Bankhead, Staff Writer, MedPage Today

Almost a third of men on active surveillance for prostate cancer had an upgrade in Gleason pathology grade during follow-up, biopsy results for almost 600 patients showed. 
< READ MORE >



September 26, 2012

Prostate MRI May Help Decide on Watchful Waiting 
SCharles Bankhead, Staff Writer, MedPage Today

MRI evaluation of clinically low-risk prostate cancer demonstrated high accuracy for predicting disease status in men evaluated for watchful waiting, data from a prospective clinical study showed. This points out that the findings support a role for MRI in the initial assessment of appropriateness for watchful waiting, or active surveillance. 
< READ MORE >


January 26, 2012

Prostate Surgery Plans Often Change After MRI
  Kurt Ullman, Contributing Writer, MedPage Today

Preoperative magnetic resonance imaging of the prostate changed the surgical plan in more than one in four patients undergoing robotic-assisted laparoscopic prostatectomy (RALP), according to the results of a single-center study.
< READ MORE >

  January 23, 2012
Drug Slows Progress of Prostate Cancer
  Charles Bankhead, Staff Writer, MedPage Today

Men with early prostate cancer had significantly less disease progression when treated with dutasteride (Avodart) than with placebo as part of active surveillance, results of a randomized trial showed.
< READ MORE >

  January 11, 2012
Researchers Find Familial Prostate Cancer Mutation
  Crystal Phend, Senior Staff Writer, MedPage Today

The first genetic mutation for prostate cancer risk in families with a strong hereditary predisposition has been found, researchers reported.
< READ MORE >

 

June 19, 2009
Green Tea May Slow Prostate Cancer

  By Kristina Fiore, Staff Writer, MedPage Today

LITTLE FALLS, N.J., June 19 -- Certain compounds in green tea may slow the progression of prostate cancer, researchers say.
< READ MORE >

 

Oct 28, 2008
Effect of Statins on PSA May Confound Biopsy Decision

  By Charles Bankhead, Staff Writer, MedPage Today

DURHAM, N.C., Oct. 28 -- Statin therapy lowers prostate-specific antigen levels, possibly confounding clinical decision-making about the need for prostate biopsy, investigators here reported.     <READ MORE>

 

Oct 6, 2008
Excess Weight, Insulin Drive Up Prostate Cancer Mortality

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Oct. 6 -- Prostate cancer patients who were overweight or had elevated C-peptide levels before diagnosis are at a significantly increased risk of dying from the disease, investigators here found.     <READ MORE>

 

Oct 3, 2008
Drainage Device May Offer Catheter-Free Prostatectomy Option

  By Charles Bankhead, Staff Writer, MedPage Today

NEW YORK, Oct. 3 -- Patients undergoing robotic radical prostatectomy had virtually none of the pain associated with a conventional urethral catheter when surgeons used an investigational bladder drain, a small pilot study showed.      <READ MORE>

 

Sept 30, 2008
ASTRO: Rectum Changes During Prostate Cancer Radiation May Affect Therapy

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Sept. 30 -- Because the size and shape of the rectum can change after the start of high-dose radiotherapy for prostate cancer, reliance on pretreatment CT for planning may underestimate the radiation toxicity, investigators reported here.      <READ MORE>

 

Sept 26, 2008
ASTRO: Lower PSA Relapse Risk Seen in Prostate Cancer Patients on Statins

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Sept. 26 -- For men with localized prostate cancer who happened to be taking statins while being treated with radiation, the risk of biochemical failure was significantly reduced, according to a retrospective analysis reported here.       <READ MORE>

 

Sept 26, 2008
ASTRO: Proton Radiation Fails to Impress in Prostate Cancer Study

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Sept. 26 -- Proton radiation for early prostate cancer had an acceptable tolerability profile but produced little evidence of a "gee whiz" impact to support its cost, according to preliminary results from a phase I/II clinical trial.       <READ MORE>

 

Sept 24, 2008
ASTRO: Hormone Therapy Before Seeds Called Bad Mix for Prostate Cancer

  By Michael Smith, North American Correspondent, MedPage Today

BOSTON, Sept. 24 -- For men older than 70 with prostate cancer, neoadjuvant hormone therapy before brachytherapy with radioactive seeds increases the risk of death, a researcher said here. <READ MORE>

 

Sept 24, 2008
ASTRO: High-Dose Brachytherapy Called Choice in Early Prostate Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Sept. 24 -- In patients with localized prostate cancer, high-dose brachytherapy seems to outdo the competition, according to results of a single-center study. <READ MORE>

 

Sept 22, 2008
ASTRO: Short Radiation Course After Lumpectomy Suggested

  By Michael Smith, North American Correspondent, MedPage Today

BBOSTON, Sept. 22 -- A shorter course of radiation therapy with a lower dose following lumpectomy is as effective as the longer standard adjuvant therapy for breast cancer, a researcher said here. <READ MORE>

 

Sept 22, 2008
ASTRO: Radiation Cuts Mortality in Locally Advanced Prostate Cancer

  By Michael Smith, North American Correspondent, MedPage Today

BOSTON, Sept. 22 -- The mortality rate from locally advanced prostate cancer was halved by adding external beam radiation to hormone therapy, a researcher said here. <READ MORE>

 

July 25, 2008
Task Force Recommends Against PSA Screening for Older Men

  By Charles Bankhead, Staff Writer, MedPage Today

WASHINGTON, Aug. 4 -- PSA screening at age 75 and older has a negligible benefit at best, according to the U.S. Preventive Services Task Force, which has recommended against doing it.     <READ MORE>

 

July 25, 2008
Early Findings Create Buzz for Potent Novel Hormone Blocker

  By Peggy Peck, Executive Editor, MedPage Today

LONDON, July 25 -- Abiraterone, a novel, potent hormone-blocker, appears to be safe for treatment of castration-resistant prostate cancer, researchers here reported.     <READ MORE>

 

July 10, 2008
Prostate Cancer Vaccine Before Hormones May Boost Survival

  By Crystal Phend, Staff Writer, MedPage Today

BETHESDA, Md., July 10 -- For nonmetastatic castration-resistant prostate cancer, an investigational poxvirus-based PSA vaccine given before second-line hormone therapy, rather than the reverse approach, might confer a survival advantage, researchers here found.      <READ MORE>

 

July 8, 2008
No Survival Benefit in Androgen Deprivation for Prostate Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

NEW BRUNSWICK, N.J., July 8 -- Primary androgen deprivation therapy offers no survival benefit to older men with localized prostate cancer, according to a review of Medicare data.     <READ MORE>

 

May 29, 2008
Estrogen Plays a Role in Prostate Cancer

  By Todd Neale, Staff Writer, MedPage Today

NEW YORK, May 29 -- An aggressive form of prostate cancer appears to be regulated through an estrogen-receptor-dependent mechanism, researchers found.      <READ MORE>

 

May 28, 2008
AUA: Studies Link Cholesterol to Prostate Cancer Recurrence

  By Charles Bankhead, Staff Writer, MedPage Today

ORLANDO, May 28 -- Controlling serum cholesterol may help reduce the risk of prostate cancer as well as heart disease, two studies reported here suggest.      <READ MORE>

 

May 23, 2008
AUA: PSA Testing Might Not Be Necessary for Older Men

  By Charles Bankhead, Staff Writer, MedPage Today

ORLANDO, May 23 -- At age 75, men who have PSA levels less than 3 ng/mL can safely discontinue routine prostate cancer screening because they have a low risk of developing aggressive disease, data from a large prospective cohort study suggest.     <READ MORE>

 

May 20, 2008
AUA: Active Surveillance Still Viable for Some Prostate Cancer Patients

  By Charles Bankhead, Staff Writer, MedPage Today

ORLANDO, May 20 -- For men with low-risk, localized prostate cancer, active surveillance remains a viable option, but not without a "small but very real" risk, new data suggest.     <READ MORE>

 

May 19, 2008
MedPage Today News: AUA: Prostate Cancer Vaccine Linked to Improved Survival in Small Trial

  By Charles Bankhead, Staff Writer, MedPage Today

ORLANDO, May 19 -- More than half of men with metastatic, hormone-refractory prostate cancer had longer-than-estimated survival after treatment with an adenovirus/PSA vaccine, showed a phase I study.     <READ MORE>

 

May 01, 2008
Gene Expression May Identify High-Risk Prostate Neoplasia

  By Charles Bankhead, Staff Writer, MedPage Today

BARCELONA, Spain, May 1 -- The risk that high-grade prostatic intraepithelial neoplasia will turn malignant may stem from overexpression of a prostate tumor gene, found investigators here.     <READ MORE>

 

Apr 18, 2008
AACR: Statin-COX2 Inhibitor Combo Slows Prostate Cancer Growth

  By Charles Bankhead, Staff Writer, MedPage Today

SAN DIEGO, April 18 -- Progression of androgen-independent prostate cancer was significantly inhibited in mice by a combination of atorvastatin (Lipitor) and celecoxib (Celebrex), according to a study reported here.     <READ MORE>

 

Mar 19, 2008
Global Look at Fallout from Prostate Cancer Therapy Reveals Buried Troubles 

  By Crystal Phend, Staff Writer, MedPage Today

BOSTON, March 19 -- Sexual dysfunction and incontinence seem to be only the better known quality-of-life downsides of therapy for prostate cancer, according to researchers here.     <READ MORE>

 

Feb 29, 2008
Angiogenesis Protein Helps Detect Prostate Cancer Nodal Status 

  By Charles Bankhead, Staff Writer, MedPage Today

DALLAS, Feb. 29 -- Nodal involvement in localized prostate cancer can be detected with near 100% accuracy prior to a prostatectomy by adding measurement of the angiogenesis modulator endoglin to a predictive model, investigators here reported.     <READ MORE>

 

Feb 19, 2008
PSA Levels Deceptively Low in Obese Men 

  By Crystal Phend, Staff Writer, MedPage Today

DURHAM, N.C., Feb. 19 -- Obesity may hide early evidence of prostate cancer by lowering prostate-specific antigen levels, according to a community-based screening study.    <READ MORE>

 

Feb 18, 2008
ASCO GU: Bisphosphonate Effective Long Term in Prostate Cancer Hormone Therapy

  By Crystal Phend, Staff Writer, MedPage Today

SAN FRANCISCO, Feb. 18 -- Zoledronic acid (Zometa) improves bone mineral density in long-term use during androgen suppression therapy for prostate cancer, researchers found.   <READ MORE>

 

Feb 15, 2008
PSA Test Before Age 50 May Predict Advanced Cancer 25 Years Later 

  By Michael Smith, North American Correspondent, MedPage Today

NEW YORK, Feb. 15 -- A single PSA test -- taken before the age of 50 -- can predict a diagnosis of advanced prostate cancer up to 25 years later, according to researchers here and in Sweden.   <READ MORE>

 

Feb 15, 2008
ASCO GU: Immediate Androgen Suppression Questioned for Node-Positive Prostate Cancer

  By Crystal Phend, Staff Writer, MedPage Today

SAN FRANCISCO, Feb. 15 -- Delaying hormone therapy for node-positive prostate cancer until disease progression may not impair survival, Dutch researchers found.    <READ MORE>

 

Feb 13, 2008
ASCO GU: Radiation Reduces Mortality Risk of Recurrent Prostate Cancer

  By Crystal Phend, Staff Writer, MedPage Today

SAN FRANCISCO, Feb. 14 -- Radiotherapy improves survival for some men with rising prostate-specific antigen (PSA) levels after radical prostatectomy, researchers found.   <READ MORE>

 

Feb 13, 2008
ASCO GU: No Prostate Cancer Treatment Needed for Most Older Men

  By Charles Bankhead, Staff Writer, MedPage Today

SAN FRANCISCO, Feb. 13 -- Watchful waiting may be safe for most older men with early-stage prostate cancer, researchers affirmed.   <READ MORE>

 

Jan 22, 2008
Comorbidity Can Confound Prostate Cancer Treatment

  By Charles Bankhead, Staff Writer, MedPage Today

BOSTON, Jan. 22 -- The best-laid plans of therapy for localized unfavorable-risk prostate cancer can be upset by pre-existing comorbidities, investigators here found.   <READ MORE>

 

Jan 16, 2008
Prostate Cancer Risk Boosted by Gene Variations Plus Family History

  By Michael Smith, North American Correspondent, MedPage Today

BALTIMORE, Jan. 16 -- The risk of prostate cancer increases dramatically in the face of five common genetic variations as well as a family history, researchers here said.   <READ MORE>

 

Jan 15, 2008
Dietary Supplement Tied to Metastatic Prostate Cancer

  By Crystal Phend, Staff Writer, MedPage Today

DALLAS, Jan. 15 -- When two patients developed unusually aggressive metastatic prostate cancer within months of starting the same muscle-building dietary supplement, researchers here started investigating.  <READ MORE>

 

Jan 3, 2008
Short-Course Hormone Therapy Provides Years of Benefit in Prostate Cancer

  By Crystal Phend, Staff Writer,, MedPage Today

SAN FRANCISCO, Jan. 3 -- Short-term neoadjuvant hormonal therapy may improve long-term prostate cancer outcomes for men with locally advanced, high-risk disease but unable to tolerate a standard course of androgen suppression.  <READ MORE>

 

Dec 27, 2007
Aspirin Therapy Can Impair Prostate Cancer Treatment

  By Crystal Phend, Staff Writer,, MedPage Today

BOSTON, Dec. 27 -- Regular use of even low-dose aspirin may interfere with androgen suppression therapy for men with prostate cancer.  <READ MORE>

 

Nov 12, 2007
Family Program Helps Patients and Spouses Cope with Prostate Cancer

  By Judith Groch, Senior Writer, MedPage Today

ANN ARBOR, Mich., Nov. 12 -- Family counseling improved the lives of prostate cancer patients and their spouses, with much of the benefit going to the care-giving spouse, researchers here reported.  <READ MORE>

 

Oct 31, 2007
ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men

  By Michael Smith, Senior Staff Writer, MedPage Today

LOS ANGELES, Oct. 31 -- Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.  <READ MORE>

 

Oct 29, 2007
ASTRO: Exercise Prevents Bone Loss from Prostate Cancer Androgen Deprivation

  By Michael Smith, Senior Staff Writer, MedPage Today

LOS ANGELES, Oct. 29 -- The bone loss associated with androgen deprivation therapy for prostate cancer, along with radiation treatment, can be prevented by a brisk walk five or six times a week, a researcher said here.  <READ MORE>

 

Sept 17, 2007
DOD Prostate: Barbers Cut to the Chase in Minority Prostate Cancer Awareness

  By Ed Susman, Contributing Writer, MedPage Today

ATLANTA, Sept. 17 -- Attacking locally advanced prostate cancer with intermittent androgen treatment may improve quality of life while maintaining the historical survival of more aggressive therapy.  <READ MORE>

 

Sept 7, 2007
DOD Prostate: Barbers Cut to the Chase in Minority Prostate Cancer Awareness

  By Ed Susman, Contributing Writer, MedPage Today

ATLANTA, Sept. 7 -- Although barbers and surgeons have long been linked in the history of medicine, the role of urologist's assistant is a new twist. Now the barbershop is becoming a clearinghouse for minority prostate cancer screening.  <READ MORE>

 

August 20, 2007
Robotic-Assisted Laparoscopic Prostatectomy Speeds Recovery

  By Denise Mann, Contributing Writer, MedPage Today

CHAPEL HILL, N.C., Aug. 20 -- A robotic-assisted laparoscopic prostatectomy seems to lead to a faster surgical recovery than an open procedure, found investigators here.  <READ MORE>

 

August 1, 2007
Prostate Cancer Viewed as Condition Linked to Fused Chromosomes

  By Michael Smith, Senior Staff Writer, MedPage Today

ANN ARBOR, Mich., Aug. 1 -- Prostate cancer may be an umbrella term for a variety of neoplastic conditions traced to fused chromosomes, according to genetic findings here.  <READ MORE>

 

July 25, 2007
Recurrence Risk after Prostatectomy Lower with Experienced Surgeons

  By Charles Bankhead, Staff Writer, MedPage Today

NEW YORK, July 25 -- For clinically localized prostate cancer, the experience of the surgeon doing a radical prostatectomy may play a major role in avoiding a biochemical relapse, according to investigators here.  <READ MORE>

 

August 15, 2007
Elevated Immune Protein May Identify High-Risk Prostate Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

ROCHESTER, Minn., Aug. 15 -- Aggressive, high-risk prostate cancers have increased expression of an immumodulatory protein that predicts relapse after treatment, investigators reported.  <READ MORE>

 

July 25, 2007
Recurrence Risk after Prostatectomy Lower with Experienced Surgeons

  By Charles Bankhead, Staff Writer, MedPage Today

NEW YORK, July 25 -- For clinically localized prostate cancer, the experience of the surgeon doing a radical prostatectomy may play a major role in avoiding a biochemical relapse, according to investigators here.  <READ MORE>

 

April 26, 2007
Hopkins Researchers Find a Better Blood Test For Prostate Cancer

  Johns Hopkins Medicine, Media Relations and Public Affairs, April 26, 2007

New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.  <READ MORE>

   

 

:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough News ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

 
Copyright ⓒ ICare.  All rights reserved.